Search

Investment of 65 million euro in avian vaccines in France

Boehringer Ingelheim is set to invest almost €65 million in a high-tech building at its Lyon Portes-des-Alpes site in Saint-Priest, France (Rhône), to meet the growing demand worldwide for avian vaccines

FIBRONEER™ Ph3 trials in patients with IPF & other PF-ILDs

Donald Zoz, M.D., Director and Senior Clinical Program Leader for Pulmonary Fibrosis, discusses the FIBRONEER™ global clinical program

Bridging the gap in Generalized Pustular Psoriasis (GPP)

Emmanuelle Clerisme-Beaty, former Head of Clinical Development and Medical Affairs, Dermatology, discusses published insights from GPP patients.

Boehringer Ingelheim Venture Fund invests precision antimicrobials

Boehringer Ingelheim Venture Fund invests in the development of precision antimicrobials

Investment social engagements in Cowtribe veterinary startup

Last-mile veterinary delivery social start-up Cowtribe first investment of Boehringer Ingelheim Social Engagements

Their dogs are their world

Corporate social responsibility in Brazil: Volunteer work and animal healthcare donations for homeless people and their pets.

Digital innovation: Our digital pipeline is only growing

BRASS, a software advancing patient safety and developed fully in-house, has been sold. This is proof: our digital innovations are in demand.

Vegetablehash video

This colourful, delicious breakfast is a great way to start the day. Watch this video to learn how to make it.

Upstream and Downstream Processing | Bioxcellence | Boehringer Ingelheim

Experience our exceptional expertise in upstream & downstream biopharmaceutical processing, utilizing mammalian cell cultures & microbial organisms.

Prevalence of VTE in the US and Europe.pdf

Effect_of_Tiotropium_and_Salmeterol_in_COPD_Patients_With .pdf

Informed decision and safe use of medications

Partnering-with-google-in-quantum-computing

New cooperation with Google explores the potentials of quantum computing for pharma R&D.

Careers: Winning with people

Our employees are the foundation of our innovative strength. We continue to put people first in everything we do and support our employees in the key moments of their careers.

FIBRONEER™ Phase III program initiated

FIBRONEER™ Phase III program initiated globally to evaluate BI 1015550, a novel investigational phosphodiesterase 4B (PDE4B) inhibitor

Strategic-collaboration-with-EnaraBio

Boehringer Ingelheim and Enara Bio enter strategic collaboration and licensing agreement to discover novel shared antigens for cancer immunotherapies.

Our Innovation Strategy

A deep understanding of disease, identifying relevant mechanisms and choosing therapeutic modalities to address them is the core of our innovation strategy

LongRange

Longrange® is effective in the control of most internal and external parasites of cattle: gastrointestinal roundworms, lungworms, grubs, mites.

Dedifferentiated liposarcoma: Life with an ultra rare cancer

For Dan, being diagnosed with dedifferentiated liposarcoma, an ultra rare sarcoma, was life changing, and means he now makes the most of every day.

Joint venture to fight Antimicrobial Resistance

Boehringer Ingelheim, Evotec and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance

Collaboration-with-OxfordBioTherapeutics

Boehringer Ingelheim collaborates with Oxford BioTherapeutics to discover tumor targets to deliver first-in-class treatments for cancer patients.

Boehringer Ingelheim announces collaboration with MabGenesis

Boehringer Ingelheim announces collaboration with MabGenesis to discover and develop novel monoclonal antibodies in canine

Ukraine Help: The heroes of Mainz-Finthen

Travis Kelley helps Olena and Wasyl flee from Ukraine. This is the record of a dramatic and emotional rescue operation.

License deal with A*STAR to develop cancer antibodies

Respiratory Diseases

We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in respiratory diseases.

About Us

Human Health

Animal Health

Science & Innovation

Partnering

Careers